Where is the live CopyMark page for USPTO serial 97262970?

The live record is at https://getcopymark.com/trademark/97262970. Use https://getcopymark.com/trademark/{serialNumber} for any 8-digit USPTO serial.

Who owns VIRION THERAPEUTICS?

According to the public USPTO record for serial number 97262970, the listed owner(s) include: Virion Therapeutics, LLC.

What is USPTO serial number 97262970?

Serial number 97262970 is the USPTO application identifier for the mark VIRION THERAPEUTICS. It is used to track examination, publication, and registration of this trademark.

What is the current status of VIRION THERAPEUTICS?

VIRION THERAPEUTICS (97262970) currently shows USPTO status code 654 on the public record. This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Which trademark classes cover VIRION THERAPEUTICS?

The public record lists International Classes: 042. Each class corresponds to categories of goods or services identified in the application or registration.

Trademark: VIRION THERAPEUTICS Serial# 97262970 | status 654; last event DOCK | Trademark Info & Attorney Guidance

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with VIRION THERAPEUTICS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner

Monitor this mark, or talk with CopyMark about this registration.

Trademark Monitoring

(312) 319-4460

Not the owner?

File a new U.S. trademark application, or speak with our attorneys.

Start a new application

(312) 319-4460

Owner

Virion Therapeutics, LLC
Newark, DE, US
Other trademarks owned by Virion Therapeutics, LLC

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Kevin M. Bovard

Kevin M. Bovard BAKER & HOSTETLER LLP1735 MARKET STREETSUITE 3300PHILADELPHIA, PA 19103-7501

Goods and services

Class	Description	Status	First use
042	Biomedical research services; research and development of vaccines and medicines; research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; scientific research; scientific research in the field of vaccines; clinical and pre-clinical development services in the nature of scientific research and conducting clinical trials for others in the fields of infectious diseases and cancers	ACTIVE	Feb 28, 2018

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Date	Code	Event	What it means
Aug 24, 2026	DOCK	ASSIGNED TO EXAMINER	—
May 20, 2026	RCCK	SUSPENSION CHECKED - TO ATTORNEY FOR ACTION	—
Nov 15, 2025	RCSC	REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED	—
May 14, 2025	RCSC	REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED	—
May 14, 2025	RCSC	REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED	—
Nov 13, 2024	RCSC	REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED	—
Oct 16, 2024	RCCK	SUSPENSION CHECKED - TO ATTORNEY FOR ACTION	—
Nov 21, 2023	RCSC	REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED	—
Apr 21, 2023	GNS3	NOTIFICATION OF LETTER OF SUSPENSION E-MAILED	—
Apr 21, 2023	GNSL	LETTER OF SUSPENSION E-MAILED	—
Apr 21, 2023	CNSL	SUSPENSION LETTER WRITTEN	—
Mar 4, 2023	TEME	TEAS/EMAIL CORRESPONDENCE ENTERED	—
Mar 3, 2023	CRFA	CORRESPONDENCE RECEIVED IN LAW OFFICE	—
Mar 3, 2023	TROA	TEAS RESPONSE TO OFFICE ACTION RECEIVED	This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 5, 2022	GNRN	NOTIFICATION OF NON-FINAL ACTION E-MAILED	A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 5, 2022	GNRT	NON-FINAL ACTION E-MAILED	A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 5, 2022	CNRT	NON-FINAL ACTION WRITTEN	A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 28, 2022	DOCK	ASSIGNED TO EXAMINER	—
Feb 16, 2022	NWOS	NEW APPLICATION OFFICE SUPPLIED DATA ENTERED	—
Feb 15, 2022	NWAP	NEW APPLICATION ENTERED	—

VIRION THERAPEUTICS